Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

10.0K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.0K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

3.0K
3.0K
Cancer Therapies02:49

Cancer Therapies

10.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K
Cancer Therapies02:49

Cancer Therapies

3.0K
3.0K
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

15.9K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
15.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outpatient coordination reform improves the sustainability of China's Urban Employee Basic Medical Insurance Fund.

Frontiers in public health·2024
Same author

Evaluation and correction methods for geometric errors of hydrostatic thrust bearings.

Scientific reports·2024
Same author

Predicting immunotherapy-related adverse events in late-stage non-small cell lung cancer with KARS G12C mutation treated with PD-1 inhibitors through combined assessment of LCP1 and ADPGK expression levels.

American journal of cancer research·2024
Same author

Enhancing genomic association studies in slash pine through close-range UAV-based morphological phenotyping.

Forestry research·2024
Same author

Engineering organoids-on-chips for drug testing and evaluation.

Metabolism: clinical and experimental·2024
Same author

Co-encapsulation of probiotic Lactiplantibacillus plantarum and polyphenol within novel polyvinyl alcohol/fucoidan electrospun nanofibers with improved viability and antioxidation.

International journal of biological macromolecules·2024
Same journal

Retraction: Long noncoding RNA XIST is a prognostic factor in colorectal cancer and inhibits 5-fluorouracil-induced cell cytotoxicity through promoting thymidylate synthase expression.

Oncotarget·2026
Same journal

TRAIL-R2 in the shadows: Epigenetic silencing and clinical implications in breast cancer.

Oncotarget·2026
Same journal

Retraction: MALAT1 predicts poor survival in osteosarcoma patients and promotes cell metastasis through associating with EZH2.

Oncotarget·2026
Same journal

Laryngeal leiomyosarcoma: A rare case report and literature review.

Oncotarget·2026
Same journal

Correction: Postsurgery fluids promote transition of cancer stem cell toendothelial and AKT/mTOR activity contributing to relapse of giant cell tumors of bone.

Oncotarget·2026
Same journal

DHHC3 interferes with antitumor immunity in melanoma cells.

Oncotarget·2026
See all related articles

Related Experiment Video

Updated: Mar 28, 2026

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG
08:46

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG

Published on: March 7, 2017

17.6K

DAB2IP in cancer.

Liang Liu1,2, Cong Xu3, Jer-Tsong Hsieh4

  • 1Tongji Cancer Research Institute, Tongji Hospital, Tongji Medical College in Huazhong University of Science and Technology, Wuhan, Hubei 430030, China.

Oncotarget
|December 15, 2015
PubMed
Summary
This summary is machine-generated.

DAB2IP, a tumor-suppressing protein, is frequently downregulated in cancers due to epigenetic changes. Its reduced expression indicates poor prognosis, but DAB2IP offers potential for targeted cancer therapies.

Keywords:
AIP1DAB2IPcancertumor suppressor

More Related Videos

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier
07:53

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Published on: April 26, 2016

11.6K
Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches
06:19

Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches

Published on: June 16, 2023

4.0K

Related Experiment Videos

Last Updated: Mar 28, 2026

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG
08:46

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG

Published on: March 7, 2017

17.6K
Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier
07:53

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Published on: April 26, 2016

11.6K
Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches
06:19

Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches

Published on: June 16, 2023

4.0K

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • DAB2IP (Disabled-2 Interacting Protein) is a Ras GTPase-activating protein family member.
  • It interacts with DAB2 and regulates cell proliferation, survival, apoptosis, and metastasis.
  • DAB2IP exhibits tumor-inhibiting activity and is part of the disable gene family.

Purpose of the Study:

  • To review the tumor-suppressive role of DAB2IP in cancer progression.
  • To elucidate the mechanisms of DAB2IP dysregulation in cancer.
  • To discuss DAB2IP's functional mechanisms and therapeutic potential.

Main Methods:

  • Literature review and synthesis of current research on DAB2IP.
  • Analysis of molecular mechanisms underlying DAB2IP dysregulation (e.g., promoter methylation, histone deacetylation).
  • Evaluation of DAB2IP's role in various cancer types based on existing studies.

Main Results:

  • DAB2IP is significantly downregulated in multiple cancer types.
  • Aberrant expression is linked to epigenetic alterations like aberrant promoter methylation and histone deacetylation.
  • Reduced DAB2IP expression correlates with poor prognosis in malignant cancers.

Conclusions:

  • DAB2IP acts as a crucial tumor suppressor in cancer progression.
  • Epigenetic modifications are key drivers of DAB2IP downregulation in neoplasms.
  • DAB2IP represents a promising target for novel cancer therapies due to its demonstrated ability to inhibit tumor growth.